Security readout for executives and security teams
Plain-English summary
CVE-2026-21980 affects Oracle Life Sciences Central Coding 7.0.1.0. An unauthenticated attacker who can reach the product over HTTP could read some accessible data and make unauthorized changes to some data. The issue is not listed as known exploited in the provided sources, but it matters because it affects confidentiality and integrity in a life sciences application.
Executive priority
Prioritize remediation for internet-facing or broadly reachable Central Coding systems, especially where regulated clinical or life sciences data is processed. Treat this as a medium-severity integrity and confidentiality risk, not a confirmed breach indicator.
Technical view
Oracle describes an easily exploitable Platform-component vulnerability in Oracle Life Sciences Central Coding 7.0.1.0. The CVSS 3.1 vector is AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N, score 6.5. Impact is limited confidentiality and integrity compromise: unauthorized read plus update, insert, or delete access to some application-accessible data. No CWE is provided in the source bundle.
Likely exposure
Exposure is most relevant where Oracle Life Sciences Central Coding 7.0.1.0 is reachable over HTTP by untrusted networks or users. Systems isolated behind VPNs, private networks, or strong access controls have reduced exposure, but the vulnerability requires no authentication once network access is available.
Exploitation context
The source states the flaw is easily exploitable over HTTP without authentication or user interaction. The provided KEV flag is false, and no cited source states active exploitation. No public exploit details are included in the source bundle.
Researcher notes
The available record does not identify the underlying weakness class, affected endpoints, or patch details. Analysis should stay anchored to Oracle’s advisory and CVE text. Avoid assuming broader Oracle Health Sciences products are affected beyond Central Coding 7.0.1.0.
Mitigation direction
- Check Oracle January 2026 CPU guidance for the Central Coding 7.0.1.0 fix path.
- Apply Oracle-provided patches or updates if available for affected deployments.
- Restrict HTTP access to trusted networks until remediation is complete.
- Review application and database access controls around sensitive coding data.
- Increase monitoring for unexpected reads, inserts, updates, or deletes.
Validation and detection
- Inventory Oracle Life Sciences Central Coding deployments and confirm version 7.0.1.0 presence.
- Confirm whether the application is reachable over HTTP from untrusted networks.
- Verify Oracle CPU remediation status for each affected instance.
- Review logs for unauthenticated access followed by data read or modification events.
- Document compensating controls if patching is delayed.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CVE-2026-21980 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Medium
- CVSS
- 6.5 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N3.92.5Primary CVE scoreVulnerability scoring details
Base CVSS 3.1 score
6.5MediumVector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N
Source materials
- CVE List V5 sourceCVE List V5
- Oracle AdvisoryCVE reference · vendor-advisory
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.